(CENTA) Central Garden & Pet - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 2.000m USD | Total Return: 1.9% in 12m
Avg Trading Vol: 10.1M USD
Peers RS (IBD): 77.3
EPS Trend: -14.9%
Qual. Beats: 0
Rev. Trend: -32.8%
Qual. Beats: 0
No concerns identified
No distinct edge detected
Central Garden & Pet Company operates in the pet and garden supply markets. The companys business model involves manufacturing and distributing a diverse range of products across two primary segments.
The Pet segment offers items for dogs, cats, aquatics, small animals, and reptiles. This includes consumables like treats and food, as well as durable goods such as toys, beds, and enclosures. The pet care market is characterized by consistent demand driven by pet ownership trends.
The Garden segment focuses on lawn and garden products, including seeds, fertilizers, wild bird supplies, and pest control solutions. The garden products industry often sees seasonal demand fluctuations.
Central Garden & Pet Company distributes its products through a wide network of retailers, including big-box stores, online platforms, and independent distributors. For more detailed financial analysis and performance metrics, further research on ValueRay is recommended.
- Pet product demand impacts revenue growth
- Garden product sales drive seasonal performance
- Input costs for raw materials pressure margins
- Retailer consolidation affects distribution channels
- Weather patterns influence garden product purchases
| Net Income: 155.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.27 > 1.0 |
| NWC/Revenue: 45.04% < 20% (prev 41.71%; Δ 3.33% < -1%) |
| CFO/TA 0.09 > 3% & CFO 331.1m > Net Income 155.7m |
| Net Debt (886.0m) to EBITDA (348.5m): 2.54 < 3 |
| Current Ratio: 3.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (62.1m) vs 12m ago -5.17% < -2% |
| Gross Margin: 32.11% > 18% (prev 0.29%; Δ 3.18k% > 0.5%) |
| Asset Turnover: 86.08% > 50% (prev 91.13%; Δ -5.05% > 0%) |
| Interest Coverage Ratio: 4.59 > 6 (EBITDA TTM 348.5m / Interest Expense TTM 57.7m) |
| A: 0.38 (Total Current Assets 1.97b - Total Current Liabilities 574.0m) / Total Assets 3.64b |
| B: 0.28 (Retained Earnings 1.01b / Total Assets 3.64b) |
| C: 0.07 (EBIT TTM 264.9m / Avg Total Assets 3.59b) |
| D: 0.49 (Book Value of Equity 1.01b / Total Liabilities 2.07b) |
| Altman-Z'' Score: 4.42 = AA |
| DSRI: 0.93 (Receivables 357.8m/399.4m, Revenue 3.09b/3.22b) |
| GMI: 0.91 (GM 32.11% / 29.31%) |
| AQI: 1.00 (AQ_t 0.31 / AQ_t-1 0.31) |
| SGI: 0.96 (Revenue 3.09b / 3.22b) |
| TATA: -0.05 (NI 155.7m - CFO 331.1m) / TA 3.64b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
Over the past week, the price has changed by -3.55%, over one month by -4.16%, over three months by +8.27% and over the past year by +1.87%.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Wallstreet Target Price | 43.8 | 38.7% |
| Analysts Target Price | 43.8 | 38.7% |
P/E Forward = 10.7066
P/S = 0.6471
P/B = 1.2478
P/EG = 1.866
Revenue TTM = 3.09b USD
EBIT TTM = 264.9m USD
EBITDA TTM = 348.5m USD
Long Term Debt = 1.19b USD (from longTermDebt, last quarter)
Short Term Debt = 52.9m USD (from shortTermDebt, last quarter)
Debt = 1.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 886.0m USD (from netDebt column, last quarter)
Enterprise Value = 2.89b USD (2.00b + Debt 1.61b - CCE 721.1m)
Interest Coverage Ratio = 4.59 (Ebit TTM 264.9m / Interest Expense TTM 57.7m)
EV/FCF = 10.13x (Enterprise Value 2.89b / FCF TTM 285.0m)
FCF Yield = 9.88% (FCF TTM 285.0m / Enterprise Value 2.89b)
FCF Margin = 9.22% (FCF TTM 285.0m / Revenue TTM 3.09b)
Net Margin = 5.04% (Net Income TTM 155.7m / Revenue TTM 3.09b)
Gross Margin = 32.11% ((Revenue TTM 3.09b - Cost of Revenue TTM 2.10b) / Revenue TTM)
Gross Margin QoQ = 30.87% (prev 28.98%)
Tobins Q-Ratio = 0.79 (Enterprise Value 2.89b / Total Assets 3.64b)
Interest Expense / Debt = 0.90% (Interest Expense 14.5m / Debt 1.61b)
Taxrate = 23.39% (2.09m / 8.93m)
NOPAT = 202.9m (EBIT 264.9m * (1 - 23.39%))
Current Ratio = 3.42 (Total Current Assets 1.97b / Total Current Liabilities 574.0m)
Debt / Equity = 1.02 (Debt 1.61b / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 2.54 (Net Debt 886.0m / EBITDA 348.5m)
Debt / FCF = 3.11 (Net Debt 886.0m / FCF TTM 285.0m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.34% (Net Income 155.7m / Total Assets 3.64b)
RoE = 9.90% (Net Income TTM 155.7m / Total Stockholder Equity 1.57b)
RoCE = 9.58% (EBIT 264.9m / Capital Employed (Equity 1.57b + L.T.Debt 1.19b))
RoIC = 7.34% (NOPAT 202.9m / Invested Capital 2.76b)
WACC = 4.38% (E(2.00b)/V(3.61b) * Re(7.34%) + D(1.61b)/V(3.61b) * Rd(0.90%) * (1-Tc(0.23)))
Discount Rate = 7.34% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 7.78%
[DCF] Terminal Value 85.49% ; FCFF base≈313.7m ; Y1≈289.2m ; Y5≈260.9m
[DCF] Fair Price = 136.1 (EV 7.83b - Net Debt 886.0m = Equity 6.94b / Shares 51.0m; r=6.0% [WACC]; 5y FCF grow -9.81% → 3.0% )
EPS Correlation: -14.88 | EPS CAGR: -41.90% | SUE: -4.0 | # QB: 0
Revenue Correlation: -32.83 | Revenue CAGR: -10.97% | SUE: -0.47 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.59 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=4
EPS current Year (2026-09-30): EPS=2.84 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+5 | Growth EPS=+4.2% | Growth Revenue=-0.2%
EPS next Year (2027-09-30): EPS=2.99 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+5.3% | Growth Revenue=+2.1%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.2% (Discount Rate 7.9% - Earnings Yield 7.8%)
[Growth] Growth Spread = +1.4% (Analyst 1.6% - Implied 0.2%)